DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aartech Solonics Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 8:17 am

Aartech Solonics

Aartech Solonics Limited has submitted a regulatory filing to the stock exchanges. The company has issued a certificate confirming its compliance with the SEBI (Depositories and Participants) Regulations, 2018. This document covers the company's activities for the quarter that ended on September 30, 2026.

For investors, this filing is a routine procedural update. It confirms that the company has maintained the necessary compliance standards with market regulators regarding its depository operations. While this news itself does not signal a major operational change, it is a positive indicator of the company's adherence to corporate governance norms.

Investors should monitor the company's future quarterly filings to ensure continued compliance. This event is a standard part of the regulatory disclosure process and does not currently indicate any specific risk or opportunity for the stock.